# MOBI (Mobia Medical, Inc.) - SEC EDGAR Financial Statements

> Mobia Medical, Inc. reported $181.2M in total assets through September 30, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/MOBI
- Markdown: https://convexityos.com/fundamentals/MOBI.md
- SEC CIK: 0001489993
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:38 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001489993&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Sep 30, 2026 |
| Operating Income | FY 2026 | -- | Operating profit |
| Net Income | FY 2026 | -- | GAAP bottom line |
| Diluted EPS | FY 2026 | -- | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $160.7M | Total debt: $1.07M |

## Income Statement

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $15.62M | $13.51M | $12.07M | $9.01M | $6.67M | $5.66M |
| Cost of Revenue | $2.62M | $2.27M | $2.13M | $1.84M | $1.18M | $1.01M |
| **Gross Profit** | $13.00M | $11.24M | $9.94M | $7.18M | $5.49M | $4.65M |
| Research & Development | $2.55M | $2.28M | $1.69M | $1.60M | $1.42M | $1.35M |
| Selling, General & Admin | $28.98M | $26.89M | $25.19M | $16.83M | $14.53M | $13.60M |
| Total Operating Expenses | $31.53M | $29.16M | $26.88M | $18.43M | $15.95M | $14.95M |
| **Operating Income** | -$18.53M | -$17.93M | -$16.94M | -$11.26M | -$10.46M | -$10.30M |
| **EBITDA** | -$18.35M | -$17.83M | -$16.88M | -$11.22M | -$10.43M | -$10.27M |
| Interest Expense | $257K | $254K | $357K | $244K | $241K | $239K |
| Income Before Tax | -$17.34M | -$21.04M | -$17.74M | -$11.42M | -$10.49M | -$10.65M |
| Income Tax Expense | $2.0K | $2.0K | $0 | $1.0K | $2.0K | $1.0K |
| **Net Income** | -$17.34M | -$21.04M | -$17.74M | -$11.42M | -$10.49M | -$10.65M |
| Basic EPS | -$0.52 | -$1.10 | -$19.30 | -$13.31 | -$12.44 | -$12.97 |
| **Diluted EPS** | -$0.52 | -$1.10 | -$19.30 | -$13.31 | -$12.44 | -$12.97 |
| Basic Shares Outstanding | 33.3M | 19.1M | 918.9K | 858.4K | 843.2K | 821.2K |
| Diluted Shares Outstanding | 33.3M | 19.1M | 918.9K | 858.4K | 843.2K | 821.2K |

## Balance Sheet

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $160.7M | $177.1M | $55.73M | $33.59M |
| **Cash & Short-Term Investments** | $160.7M | $177.1M | $55.73M | $33.59M |
| Accounts Receivable, Net | $7.00M | $5.66M | $4.85M | $4.43M |
| Inventory | $8.35M | $6.95M | $6.05M | $5.46M |
| Other Current Assets | $2.17M | $2.45M | $1.59M | $1.94M |
| **Total Current Assets** | $178.2M | $192.1M | $71.71M | $46.36M |
| Property, Plant & Equipment, Net | $1.94M | $2.06M | $738K | $669K |
| Other Non-Current Assets | $143K | $143K | $143K | $55K |
| **Total Non-Current Assets** | $2.94M | $3.13M | $1.88M | $1.79M |
| **Total Assets** | $181.2M | $195.3M | $73.60M | $48.15M |
| Accounts Payable | $3.30M | $2.36M | $3.03M | $2.22M |
| **Total Current Liabilities** | $15.12M | $14.47M | $11.83M | $10.21M |
| **Total Non-Current Liabilities** | $8.14M | $8.20M | $49.74M | $8.94M |
| **Total Liabilities** | $23.26M | $22.68M | $61.57M | $19.15M |
| **Total Debt (incl. Leases)** | $1.07M | $1.15M | $1.23M | $1.31M |
| Common Stock | $333K | $333K | $10K | $9.0K |
| Retained Earnings | -$213.9M | -$196.6M | -$175.5M | -$157.8M |
| **Total Stockholders' Equity** | $157.9M | $172.6M | -$167.7M | -$150.8M |
| Total Equity | $157.9M | $172.6M | -$167.7M | -$150.8M |

## Cash Flow Statement

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$17.34M | -$21.04M | -$17.74M | -$11.42M | -$10.49M | -$10.65M |
| Depreciation & Amortization | $177K | $100K | $56K | $39K | $32K | $31K |
| Stock-Based Compensation | $2.56M | $1.61M | $407K | $406K | $404K | $201K |
| Change in Receivables | -$1.34M | -$810K | -$419K | -$1.81M | -$458K | $409K |
| Change in Inventory | -$1.40M | -$900K | -$593K | -$461K | -$590K | -$486K |
| Change in Payables | $942K | -$187K | $727K | $305K | -$1.24M | $1.52M |
| **Operating Cash Flow** | -$12.92M | -$15.67M | -$17.73M | -$11.59M | -$11.00M | -$9.72M |
| Capital Expenditure | -$58K | -$1.54M | -$42K | -$236K | $0 | -$23K |
| **Free Cash Flow** | -$12.98M | -$17.21M | -$17.77M | -$11.83M | -$11.00M | -$9.75M |
| **Investing Cash Flow** | -$58K | -$1.54M | -$42K | -$236K | $0 | -$23K |
| **Financing Cash Flow** | -$3.42M | $138.6M | $39.91M | $37K | $11K | $32.42M |
| **Net Change in Cash** | -$16.40M | $121.4M | $22.14M | -$11.79M | -$10.99M | $22.68M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Current Ratio | 11.79x | 13.28x | 6.06x | -- | -- | -- |
| Quick Ratio | 11.24x | 12.80x | 5.55x | -- | -- | -- |
| Debt to Equity | 0.01x | 0.01x | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | +73.3% | +102.4% | +113.3% | -- | -- | -- |
| Gross Profit Growth (YoY) | +81.2% | +104.7% | +114.0% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
